Treatment of type 2 diabetic patients

23.10.2015 – Our study, A retrospective nationwide cohort study to investigate the treatment of type 2 diabetic patients in Finland – DAHLIAis now registered under the ENCePP Seal. The purpose of this study is to describe type 2 diabetes mellitus patients in Finland, especially their antidiabetic medication use and to discuss the progression of the disease in terms of comorbidities and drug treatment. As a secondary objective the study includes health economic characteristics.